Press/Media
- 25 - 50 out of 630 results
Search results
-
Melanoma, Merck vaccines still showing promise in clinical trials
17/04/23
3 items of Media coverage
Press/Media
-
Personalized Vaccine, Immunotherapy Drug Keep Patients With Melanoma Cancer Free for Over a Year [Study]
17/04/23
1 item of Media coverage
Press/Media
-
mRNA vaccine for melanoma reduces relapse after therapy, trial finds
16/04/23
5 items of Media coverage
Press/Media
-
A vaccine achieves encouraging results in the battle against the deadliest skin cancer
16/04/23
1 item of Media coverage
Press/Media
-
-
Personalized vaccine for melanoma may stave off cancer’s return
16/04/23
1 item of Media coverage
Press/Media
-
New Multiple Myeloma Study Findings Recently Were Reported by Researchers at Icahn School of Medicine at Mount Sinai (Interventions and Outcomes of Patients With Multiple Myeloma Receiving Salvage Therapy After Bcma-directed Car T Therapy)
David Melnekoff, Joshua Richter, Samir Parekh, Sundar Jagannath & Ajai Chari
13/04/23
1 item of Media coverage
Press/Media
-
-
Rusfertide Improves Responses, Meets Primary End Point of REVIVE Trial in Polycythemia Vera
3/04/23
1 item of Media coverage
Press/Media
-
Recap: Teclistamab in Multiple Myeloma: A Patient's Journey
3/04/23
1 item of Media coverage
Press/Media
-
Recap: Teclistamab in Multiple Myeloma: A Patient’s Journey
2/04/23
1 item of Media coverage
Press/Media
-
Findings from Medical University of Vienna Broaden Understanding of Urothelial Cancer (Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract ...)
John Sfakianos & John Pfail
29/03/23
1 item of Media coverage
Press/Media
-
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma
22/03/23
1 item of Media coverage
Press/Media
-
Data on Liver Cancer Detailed by Researchers at Icahn School of Medicine at Mount Sinai (Unannotated Small Rna Clusters Associated With Circulating Extracellular Vesicles Detect Early Stage Liver Cancer)
Parissa Tabrizian, Robert Sebra, Myron Schwartz, Navneet Dogra & Augusto Villanueva Rodriguez
16/03/23
1 item of Media coverage
Press/Media
-
FABA holding virtual workshop on drug discovery from March 13
11/03/23
1 item of Media coverage
Press/Media
-
CheckMate 274 follow up data boost nivolumab potential for high-risk bladder cancer
8/03/23
1 item of Media coverage
Press/Media
-
Researcher at Department of Radiation Oncology Describes Research in Head and Neck Cancer (Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy)
Daniel Dickstein & Richard Bakst
7/03/23
1 item of Media coverage
Press/Media
-
Study Findings from Icahn School of Medicine at Mount Sinai Advance Knowledge in Radiation Oncology (Gender Differences in the Research Productivity of Radiation Oncology Resident Graduates in the United States: 2015 to 2019)
Anthony Nehlsen, Eric Lehrer, Kunal Sindhu, Sheryl Green, Karyn Goodman & Brianna Jones
6/03/23
1 item of Media coverage
Press/Media
-
Study Results from Icahn School of Medicine at Mount Sinai Update Understanding of Radiation Oncology (The Rise of Open Access Journals in Radiation Oncology: Influence on Resident Research, 2015 to 2019)
Anthony Nehlsen, Eric Lehrer, Stanislav Lazarev, Kunal Sindhu, Brianna Jones, Michael Buckstein, Andrew Smith & Kenneth Rosenzweig
6/03/23
1 item of Media coverage
Press/Media
-
Mount Sinai Health System: Immunotherapy After Surgery Provides Significant, Durable Benefit for High-Risk Bladder Patients
17/02/23
1 item of Media coverage
Press/Media
-
Immunotherapy after surgery provides significant, durable benefit for high-risk bladder patients
16/02/23 → 17/02/23
2 items of Media coverage
Press/Media
-
Experimental cancer therapy shows success in more than 70% of patients in global clinical trials;
16/02/23
1 item of Media coverage
Press/Media
-
US Patent Issued to Icahn School of Medicine at Mount Sinai on Feb. 14 for "Method of predicting graft versus host disease" (New York Inventors)
14/02/23
1 item of Media coverage
Press/Media